AbbVie Stock Falls 4% -- What Investors Need to Know

Key Points AbbVie's third-quarter results were pretty strong, and the company increased its guidance. It was not enough to impress the market, which apparently expected more from the drugmaker. AbbVie's future remains bright, though, and its dividend program looks rock solid as always. 10 stocks we like better than AbbVie › Earnings season creates short-term winners and losers, companies whose shares rise or fall after they announce their quarterly updates. The good news is that among these short ...